Crystal engineering of multiple-component organic solids: Pharmaceutical cocrystals of tadalafil with persistent hydrogen bonding motifs

被引:35
作者
Weyna, David R. [1 ]
Cheney, Miranda L. [1 ]
Shan, Ning [1 ]
Hanna, Mazen [1 ]
Wojtas, Lukasz [2 ]
Zaworotko, Michael J. [2 ]
机构
[1] Thar Pharmaceut Inc, Tampa, FL 33612 USA
[2] Univ S Florida, Dept Chem, Tampa, FL 33620 USA
关键词
SELECTIVE PDE5 INHIBITOR; PHARMACOKINETICS; SOLUBILITY; DISCOVERY;
D O I
10.1039/c2ce06574f
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Pharmaceutical cocrystals of tadalafil with methylparaben, propylparaben and hydrocinnamic acid have been prepared and characterized. The crystal packing observed in the three resulting cocrystals reveals that tadalafil molecules form persistent hydrogen-bonded chains which accept additional hydrogen bonds from the OH moieties of the respective coformers.
引用
收藏
页码:2377 / 2380
页数:4
相关论文
共 31 条
[1]   The Cambridge Structural Database: a quarter of a million crystal structures and rising [J].
Allen, FH .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 2002, 58 (3 PART 1) :380-388
[2]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]  
[Anonymous], 2008, US Pat., Patent No. [20080009502 A1, 20080009502]
[4]  
[Anonymous], 2007, US Pat., Patent No. [20070104792 A1, 20070104792]
[5]  
[Anonymous], 2009, US Pat., Patent No. [2008/0009502A1, 20080009502]
[6]   Solvates of sildenafil saccharinate. A new host material [J].
Banerjee, Rahul ;
Bhatt, Prashant M. ;
Desiraju, Gautam R. .
CRYSTAL GROWTH & DESIGN, 2006, 6 (06) :1468-1478
[7]   Cocrystals of Caffeine and Hydroxybenzoic Acids Composed of Multiple Supramolecular Heterosynthons: Screening via Solution-Mediated Phase Transformation and Structural Characterization [J].
Bucar, Dejan-Kresimir ;
Henry, Rodger F. ;
Lou, Xiaochun ;
Duerst, Richard W. ;
MacGillivray, Leonard R. ;
Zhang, Geoff G. Z. .
CRYSTAL GROWTH & DESIGN, 2009, 9 (04) :1932-1943
[8]   Coformer Selection in Pharmaceutical Cocrystal Development: a Case Study of a Meloxicam Aspirin Cocrystal That Exhibits Enhanced Solubility and Pharmacokinetics [J].
Cheney, Miranda L. ;
Weyna, David R. ;
Shan, Ning ;
Hanna, Mazen ;
Wojtas, Lukasz ;
Zaworotko, Michael J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (06) :2172-2181
[9]   Supramolecular Architectures of Meloxicam Carboxylic Acid Cocrystals, a Crystal Engineering Case Study [J].
Cheney, Miranda L. ;
Weyna, David R. ;
Shan, Ning ;
Hanna, Mazen ;
Wojtas, Lukasz ;
Zaworotko, Michael J. .
CRYSTAL GROWTH & DESIGN, 2010, 10 (10) :4401-4413
[10]   Effects of Crystal Form on Solubility and Pharmacokinetics: A Crystal Engineering Case Study of Lamotrigine [J].
Cheney, Miranda L. ;
Shan, Ning ;
Healey, Elisabeth R. ;
Hanna, Mazen ;
Wojtas, Lukasz ;
Zaworotko, Michael J. ;
Sava, Vasyl ;
Song, Shijie ;
Sanchez-Ramos, Juan R. .
CRYSTAL GROWTH & DESIGN, 2010, 10 (01) :394-405